Topic - Barbara Davit

Subscribe to this topic via RSS or ATOM
Related Stories
  • No Stories Found

More Stories →

Quotations
  • Davit said the agency traditionally tests the lower dose of antidepressant drugs to avoid unnecessarily exposing patients to high doses.

    Defective generic pill revives quality concerns →

  • "Based on the information we had available at that time we concluded that the 150 milligram strength was doing what it should, and that it was acceptable to extrapolate those findings to the 300 milligram strength" said Barbara Davit, director of bioequivalence for FDA's office of generic drugs.

    Defective generic pill revives quality concerns →

Happening Now